The researcher couldn’t get Mallory Smith’s story out of her mind. Smith was a 25-year-old cystic fibrosis patient, and she was near death at a Pittsburgh hospital, her lungs overwhelmed by bacteria. All antibiotics had failed. As a last resort, her father suggested an experimental treatment known as phage therapy.
The era of antibiotics that began almost a century ago is coming to an end. Diseases that were once easily treatable have become resistant to even the most potent antibiotics. Around the globe, drug-resistant infections claim hundreds of thousands of lives a year; according to one report, the toll of infectious disease deaths could rise […]
In 1915, British scientist Frederick Twort saw something weird happening to the bacteria that had invaded his viral cultures: They were disappearing, a sign they had been destroyed. Two years later, French-Canadian microbiologist Félix d’ Hérelle observed the same phenomenon in his own lab. Both researchers, working independently, concluded that the viruses they had been […]
When Thomas Patterson woke up from a two-month coma in March 2016, he learned two things he couldn’t believe: Donald Trump was soon to become the Republican nominee for president, and his wife, Steffanie Strathdee, had saved him from dying of an antibiotic-resistant superbug by injecting him with viruses harvested from sewage.
Scientists have long dismissed “phage therapy” as a fringe idea pushed by eccentrics who enjoy fishing in sewage. But now the Navy is betting on it. Two days after walking through the pyramids, Tom Patterson got very sick. The psychiatry professor was in Egypt with his wife on one of their many adventurous vacations away from […]
April 26, 2017 07:07 PM Eastern Daylight Time GAITHERSBURG, Md.–(BUSINESS WIRE)–Today, Adaptive Phage Therapeutics, Inc. (APT), a clinical-stage company founded to provide an effective therapeutic response to the global rise of multi-drug resistant (MDR) pathogenic bacteria, announced that a therapeutic approach leveraging bacteriophage (phage), as outlined in 2003 by NIH Emeritus Scientist, Carl R Merril, MD, (Merril, et al, Nature Reviews; […]
Intravenous viruses are used to target deadly bacterium; dramatic case suggests potential alternative to failing antibiotics